| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-07-09 16:12:21 UTC |
|---|
| Update Date | 2019-07-23 07:15:34 UTC |
|---|
| HMDB ID | HMDB0061010 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Noralfentanil |
|---|
| Description | Noralfentanil is a metabolite of alfentanil. Alfentanil (R-39209, trade name Alfenta, Rapifen in Australia) is a potent but short-acting synthetic opioid analgesic drug, used for anaesthesia in surgery. It is an analogue of fentanyl with around 1/4 the potency of fentanyl and around 1/3 of the duration of action, but with an onset of effects 4x faster than fentanyl. It is an OP3 mu-agonist. (Wikipedia) |
|---|
| Structure | CCC(=O)N(C1=CC=CC=C1)C1(COC)CCNCC1 InChI=1S/C16H24N2O2/c1-3-15(19)18(14-7-5-4-6-8-14)16(13-20-2)9-11-17-12-10-16/h4-8,17H,3,9-13H2,1-2H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 4-MPPP | HMDB | | N-(4-(Methoxymethyl)-4-piperidinyl)-N-phenylpropanamide | HMDB | | Noralfentanil, (phenyl-3-t)-labeled CPD | HMDB |
|
|---|
| Chemical Formula | C16H24N2O2 |
|---|
| Average Molecular Weight | 276.374 |
|---|
| Monoisotopic Molecular Weight | 276.183778022 |
|---|
| IUPAC Name | N-[4-(methoxymethyl)piperidin-4-yl]-N-phenylpropanamide |
|---|
| Traditional Name | N-[4-(methoxymethyl)piperidin-4-yl]-N-phenylpropanamide |
|---|
| CAS Registry Number | 61086-18-8 |
|---|
| SMILES | CCC(=O)N(C1=CC=CC=C1)C1(COC)CCNCC1 |
|---|
| InChI Identifier | InChI=1S/C16H24N2O2/c1-3-15(19)18(14-7-5-4-6-8-14)16(13-20-2)9-11-17-12-10-16/h4-8,17H,3,9-13H2,1-2H3 |
|---|
| InChI Key | ULOZGJWEIWAWML-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as anilides. These are organic heterocyclic compounds derived from oxoacids RkE(=O)l(OH)m (l not 0) by replacing an OH group by the NHPh group or derivative formed by ring substitution. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Anilides |
|---|
| Direct Parent | Anilides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Anilide
- Piperidine
- Tertiary carboxylic acid amide
- Amino acid or derivatives
- Carboxamide group
- Carboxylic acid derivative
- Dialkyl ether
- Secondary aliphatic amine
- Ether
- Secondary amine
- Organoheterocyclic compound
- Azacycle
- Organonitrogen compound
- Carbonyl group
- Organooxygen compound
- Organopnictogen compound
- Organic oxygen compound
- Organic oxide
- Amine
- Hydrocarbon derivative
- Organic nitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.43 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.0003 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.23 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1243.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 194.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 141.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 164.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 53.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 256.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 298.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 265.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 736.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 302.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1002.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 233.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 235.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 340.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 296.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 29.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Noralfentanil,1TMS,isomer #1 | CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN([Si](C)(C)C)CC1 | 2154.2 | Semi standard non polar | 33892256 | | Noralfentanil,1TMS,isomer #1 | CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN([Si](C)(C)C)CC1 | 2210.5 | Standard non polar | 33892256 | | Noralfentanil,1TMS,isomer #1 | CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN([Si](C)(C)C)CC1 | 2829.3 | Standard polar | 33892256 | | Noralfentanil,1TBDMS,isomer #1 | CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN([Si](C)(C)C(C)(C)C)CC1 | 2402.3 | Semi standard non polar | 33892256 | | Noralfentanil,1TBDMS,isomer #1 | CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN([Si](C)(C)C(C)(C)C)CC1 | 2404.3 | Standard non polar | 33892256 | | Noralfentanil,1TBDMS,isomer #1 | CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN([Si](C)(C)C(C)(C)C)CC1 | 2954.5 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Noralfentanil GC-MS (Non-derivatized) - 70eV, Positive | splash10-004l-7960000000-e3902ef7785f3e4fcae7 | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Noralfentanil GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Noralfentanil GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Noralfentanil 10V, Positive-QTOF | splash10-004i-0090000000-b50f8d64da344bd3f0d4 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Noralfentanil 20V, Positive-QTOF | splash10-0551-6690000000-bb9bf87f38d973378d29 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Noralfentanil 40V, Positive-QTOF | splash10-0a73-9510000000-0eee630156a75a36bed4 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Noralfentanil 10V, Negative-QTOF | splash10-004i-0090000000-255fc5f958d9915651e1 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Noralfentanil 20V, Negative-QTOF | splash10-00mt-2390000000-fbc2b068bf2b3541abff | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Noralfentanil 40V, Negative-QTOF | splash10-05fu-6930000000-3bf8909d6063abcd58df | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Noralfentanil 10V, Negative-QTOF | splash10-004i-0090000000-1213655852961d5e7fbf | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Noralfentanil 20V, Negative-QTOF | splash10-052g-9800000000-64ce4e6b4b9c955d7b35 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Noralfentanil 40V, Negative-QTOF | splash10-0006-9710000000-7b6db57377a8449e2a00 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Noralfentanil 10V, Positive-QTOF | splash10-004i-0090000000-fb5857ed89f2e0e25f59 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Noralfentanil 20V, Positive-QTOF | splash10-002b-9670000000-d9df0f9e679f27e0a446 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Noralfentanil 40V, Positive-QTOF | splash10-002v-6900000000-a50554a475db51dc35c3 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|